how employers are cutting off insurance coverage for weight-loss drugs like Ozempic and Wegovy. Learn about the impact on workers and healthcare costs. Weight Loss Drugs and insurance Coverage The increasing popularity of weight-loss drugs, including Ozempic and Wegovy, has led to a surge in insurance coverage costs, prompting some employers to make tough decisions. … Read more
Novo Nordisk and Eli Lilly face lawsuit over Ozempic and Mounjaro, accused of failing to warn about severe stomach problems like Stomach Paralysis gastroparesis Ozempic ,Mounjaro Sued on Stomach Paralysis Claims In a recent lawsuit, Novo Nordisk and Eli Lilly, the drugmakers behind the blockbuster drugs Ozempic and Mounjaro, are facing allegations of failing to … Read more
How pharma lobbying for weight loss drugs is gaining momentum. Learn about TROA’s impact, demand surge, and Novo Nordisk’s role. Pharma Lobbying for Weight Loss Drugs The growing popularity of weight loss drugs such as Wegovy, Ozempic, and Mounjaro owes much to their endorsement by celebrities and influencers. However, the path to success for these … Read more